Medical Claims Require Trials, Not AI Hype
-AI has nothing to do with it. You are selling bullshit. If your AI can determine which person ‘needs’ which peptide, you will need a trial to show that. -Palantir has nothing to do with it - You can sell anything you want but if you make a medical claim, you will get regulated.
Comprehensive Genomic Panel Broadens Oncology Treatment Options
Unique Features of a Comprehensive Genomic Profiling Panel: Expanding Treatment Options in a Value-Based Community Oncology Network [Mar 9, 2026] La Porte et al. @DrEzraCohen @JCOPO_ASCO https://t.co/tDi3kbxdvX #PrecisionMedicine #hemeonc @TempusAI https://t.co/zgEw8hfFia
Real-World Data Reveal Molecular Profile of Metastatic ILC
Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity [Sep 10, 2025] Davis et al. @CCR_AACR https://t.co/eY0etUfQhQ #bcsm #PrecisionMedicine #camoldx @TempusAI https://t.co/oDkC1Ua6DS
Somatic Immune Cell Mutations Linked to Autoimmunity
New evidence that somatic mutations in immune cells can be the basis for autoimmune disease @Nature https://t.co/GvzxLYgvfw
RUNX1 Identified as Key to Rejuvenate Aging T Cells
Discovery of a factor (RUNX1) that pinpoints T cell senescence and restoring its functionality achieves T cell rejuvenation. Significant implications in older adults with loss of immune system protection. https://t.co/X58DvzIUXY @ImmunityCP https://t.co/hzL3zFiPMm
GLP‑1 Receptors Protect Liver in Mouse MASH Model
Adding to the GLP-1 drug weight-loss independent effect benefit : impact on liver sinusoidal endothelial cell GLP-1 receptors for liver protection in mouse MASH model @Cell_Metabolism @DanielJDrucker @ChusaGzlzRellan https://t.co/0A13QYgm05
Anti‑parasitic Drugs Aren’t Cancer Cures, Just Profit Scheme
The congresswoman is wrong. These anti-parasitic drugs do not treat cancer, they’re pedaled by wellness influencers because they are cheap to purchase in bulk, re-package and sell with expensive telehealth visits. It’s for their expensive homes and yachts. Most Americans...
Scientists Map Light Cues for Optic Nerve Regeneration
Scientists are working on regenerating optic nerves for people who have lost their sight. The first step is done: A map of how changes in light, color, and frequency affect the visual axis. https://spectrum.ieee.org/optic-nerve-damage-electrical-stimulation
Healthcare Innovates While Delivery Model Stagnates After Century
Two things can be true. Healthcare is genuinely world class at innovation. And the model of how it delivers care to patients has remained unchanged for over a century. New Lifers episode this week with @AccessTeleCare: Spotify: https://t.co/ynEfLfzYQo Apple: https://t.co/YGNFD6eNpP Youtube: https://t.co/DFgYyMx95q
Low P‑tau217 Indicates Minimal Alzheimer’s Risk in Seniors
Another study indicative of predictive power of p-tau217 for Alzheimer's disease in cognitively unimpaired older adults (mean age 71 at baseline) A very low p-tau217 denoted minimal risk https://t.co/6RPJcCloWI https://t.co/XikzsvJjhM
AI Expands From Radiology to Entire Healthcare Operations
AI in healthcare started with radiology, from 0 to mainstream in 5 years. But something bigger is happening. AI is now transforming patient pathways, workflows, and healthcare operations beyond image analysis. Join our masterclass with Jan Beger & @HLTHEVENT next week. Limited...
PhaseV Sponsors Timmerman Traverse for Young Cancer Researchers
PhaseV Steps Up for Young Cancer Researchers. New Major Sponsor of Timmerman Traverse for Damon Runyon Cancer Research Foundation. Next trip: Sierras, Aug. 2-5. https://t.co/lvbuUGj0A6
Irregular, Short Sleep Boosts Major Heart Event Risk
One bedtime habit may significantly reduce heart risks https://t.co/D8A1qEMmri "A new study examined the association between sleep habits and heart disease. After getting 7 days of sleep data from the participants, the researchers used the following 10 years of health data...
AI‑designed Sensors Promise Earlier Cancer Detection
As a medical school professor, I can tell you: we catch most cancers too late. MIT and Microsoft may have just changed that forever. They built an AI system called CleaveNet that designs molecular sensors detecting cancer enzymes called proteases --...
Lilly to Acquire CrossBridge Bio in $300 M Deal
NEW: Eli Lilly has agreed to acquire CrossBridge Bio, the Houston-based ADC specialist led by @Mykalt45 I talked with Michael Torres on his run as a first-time CEO ending with a potential $300M deal: https://t.co/PPk3ZWL5SR
Low HRV Significantly Increases Heart Attack and Death Risk
1/2) Heart rate variability (HRV). You’ve probably heard of it—but do you actually understand it? It’s incredibly important metric. Low HRV is associated with ~50% higher risk of heart attack, even after accounting for common confounders. And... In people who’ve already had...
Alpha‑gal Syndrome Cases Surge 100‑fold, Becoming Public Health Crisis
Here is what Ask Gemini has to say about it. Is Alpha gal syndrome getting worse? The short answer is yes. Alpha-gal syndrome (AGS) is currently experiencing a significant surge in both reported cases and geographic spread. What was once a "medical...
Tick Bites Can Trigger Red Meat Allergy (Alpha‑gal)
I now have two friends that are dealing with this. It is no joke, and pray I never have to deal with this as much as I love red meat. This is going to become a bigger story soon....
Special Issue Highlights Advances in Secondary Organic Psychosis
New from us: 🗞️Special issue on secondary ("organic") psychosis just out in Schizophrenia Research edited by @_GrahamBlackman and me, but very much led by Graham: https://t.co/GL2VvvW4QK Excellent articles on pressing clinical and scientific issues from a host of authors👇 https://t.co/7Yjb09SsdS
GLP‑1 Weight Loss Meds Now Delivered Nationwide, No Clinic Visit
This box ada GLP-1 injection dalam tu… and it’s going all the way to Sabah. 🤯 Yes, Sabah. Not a normal Shopee parcel. Proper, doctor-prescribed weight loss medication. Ramai orang tak tahu — you no longer have to be in a physical “clinic”...
More Accountability, Not Less, Protects Mental Health
We're talking again on Threads about coaches and therapists - here are my thoughts. 1. Accountability matters. Working with mental health comes with tremendous, literal life and death risk. The entire purpose of licensing is to protect the public from...
Students Must Practice Moral Courage Now
Medical students know when something is wrong in clinical training. They're not lacking moral courage. They're experiencing moral isolation. Called "student one" instead of by name. Removed from roles because of their skin color. Managing food insecurity between rotations. And...
SGLT2 Inhibitors Protect Kidneys, Yet Raise Non‑Renal Risks
Sodium-Glucose Cotransporter-2 Inhibitors and Acute Kidney Injury Risk: A Systematic Review and Meta-Analysis of Randomized Trials "SGLT2is conferred substantial renoprotective benefits but increases the risk of certain nonrenal AEs." https://t.co/n0yhZgcShy
AR‑Enhanced Ultrasound Projects Anatomy Directly Onto Patients
What is the point of using augmented reality and ultrasound imaging together? Instead of interpreting flat, abstract images on a screen, clinicians can see anatomy overlaid directly onto the patient’s body in real time. If they learn how to exploit this...
AI Threatens Medical Expertise; Recommendations to Prevent Deskilling
In today's @washingtonpost, a terrific piece on the risk of AI-based deskilling in medicine, along with some sensible recommendations. I'm quoted, along with @CarlaPughMDPhD. Authors: Rebecca Adams/Laura Landry. https://t.co/eDlBmNvyXV
Join OARSI PTOA Meeting: Updates & Involvement Opportunities
Join us for the annual @OARSInews PTOA Discussion Group Meeting on Friday 24 April @ #OARSI2026 We will be sharing updates from our PTOA research priority setting, definition & prevalence working groups - lots of opportunities to get involved https://t.co/AlrAwcrhRb
Alzheimer's May Be Multifactorial End‑Stage, Not Single Cause
Absolutely astounding that two of the most interesting candidates for lowering Alzheimer’s risk in the last decade came accidentally: GLP-1 drugs and the shingles vaccine. Really suggests Alzheimer’s has no true “cause”, but is the end stage of a long, complex...
Navy SEAL and Doctor Discuss Stem Cell Breakthroughs
Great podcast with my good friend and Navy Seal William Clark and Dr. Harmon on Stem Cells https://t.co/BDKfPiMHnF
Vaccinate Anytime: RSV and Measles Protection Still Available
It’s not too late to make sure you are protected against RSV. It's never too late to make sure you are protected against measles. https://t.co/BVayTHRMJz
AI Access to All Data Exposes Waste and Fraud
Profound thought here by @sundeep ⬇️ in a world where AI is a relentless optimizer, waste, excess and fraud will be easily spotted if AI is given access to all of the data and it systems.
Ask What Relieves, Not What Inspires, When Burned Out
Burned-out doctors keep chasing "what's my passion?" Wrong question. Chelsea Turgeon says ask "what feels like relief?" Get to baseline first. The vision comes after you can breathe again. What gave you relief? #burnout #medtwitter https://t.co/Zlp0oqd7BR
Unexpected Surge: Many Companies Join CMMI ACCESS Model
Massive number of companies enrolled as participants for the CMMI ACCESS model. Way more than I expected, especially given comments around price being too low. Full list here: https://t.co/OAJPpzFtUk
Proline‑mediated Dichloromethyl Tagging Enables Ultra‑pure Drug Synthesis
A new method uses the amino acid proline to precisely attach dichloromethyl groups to complex molecules, enabling ultra-pure drug synthesis with built-in quality control and expanding possibilities for advanced medicine design. drugdiscovery
Recessions Reduce Deaths, Especially From Fewer Commutes
Ironically a well-established finding in health economics is that deaths *fall* during recessions. This is, in part, because people aren’t commuting and so driving-related deaths fall.
Healthcare Shifts From Cost Center to Strategic Risk
We’re seeing this firsthand in many places. Healthcare is no longer a line item, it’s a strategic risk. If we don’t fundamentally rethink how care is delivered and paid for, it will continue to erode margins and limit growth. https://t.co/rOx2TUN5yM
Personal Loss Exposes Danger of Dismissing Cancer Breakthroughs
Hype is bad. That includes calling an unprecedented advance in cancer treatment hype when it is not. Don’t think about the knee jerk comment this tweet is replying to. Think about this man’s wife getting three vacations.
Stair‑Climbing Electric Chair Revolutionizes Mobility
This Electric Chair Climbs Stairs Effortlessly—A Game-Changer for Mobility by @Khulood_Almani #Healthcare #TechForGood #EmergingTech #Technology #Innovation #Tech https://t.co/cmPXzZc7II
Why Anthropic Chose Coefficient Bio Over Bigger Rivals?
Reading up on the Coefficient Bio deal. I totally get the industrial logic around why Anthropic should care about drug discovery. But why this particular company? There's lots of more scaled players doing this. Can anyone educate me? https://t.co/akFVmRUaYw
Get Real Sleep Advice From a Certified Doctor
I'm not saying Trump stole my photo idea… but the timing is suspicious. He says it's a doctor. I AM a doctor. And my patient actually has a CPAP on. If you want real sleep help from a real sleep doctor instead...
DeepSeqAI Trains on Function to Future‑proof Biologics
Most AI protein tools are trained on structure. DeepSeqAI trains on function. They're running billions of experimental protein-protein interactions through their platform to map biologics against viruses, immune receptors, and the entire human proteome. The goal: candidates that hold up against...
CRISPR Turns 25: Explore Its Past, Present, Future
Introducing the GEN Keynote Webinar: "CRISPR at 25: The Past, Present, and Future of Genome Editing" Guest speaker: Rodolphe Barrangou @CRISPRchef May 4, 2026: noon ET/9 am PT Sponsored by @elevatebio https://t.co/cYsSsaod4Y via @GENbio
Busy Biotech Day Highlights Promising Advances and Insightful Commentary
As usual, excellent summary by @ldtimmerman @timmermanreport of busy and promising biotech news day - as always delivered w insight and heart (especially thoughtful comments re: revmed drug in context of poignant recent @BenSasse interview)
Delaying Generics Boosts Profits Far More than Small Gaps
That gap doesn't look like it could be the largest price-fixing scam in history. it looks like 4% of a generic drug's price. Brand drugs sell for 10-20 times as much as generics, Delaying generic entry by even 6 months...
Invest Aggressively in Value Partnerships for Better, Cheaper Care
This is exactly why we should invest more aggressively in value-based partnerships and digital health solutions. The goal isn’t just cost reduction-it’s better outcomes at a lower total cost. #healthcare #payers https://t.co/rOx2TUN5yM
Off‑the‑Shelf CAR‑T Shows Promise Delaying Lymphoma Relapse
Allogene data suggest ‘off-the-shelf’ CAR-T could delay relapse in lymphoma https://t.co/UrSNYpQFqB by @gwendolynawu $ALLO + 25%
Pancreatic Cancer Drug Nearly Doubles Survival in Trial
Revolution pancreatic cancer drug nearly doubles survival in key trial https://t.co/SvJicU0LIz @ByJonGardner $RVMD + 38%
AI Company Becomes First Autonomous Drug Prescriber in Utah
An editorial @JAMA_current on @doctronic (the AI company now prescribing renewal medications without physician involvement in Utah) entitled "The First AI Drug Prescriber" https://t.co/Wo1rVhnr4s https://t.co/hAcYbYLmIv
Health Gorilla Misses Multiple Court Deadlines, Faces Default
@healthgorilla just let a federal class action go unanswered. Plaintiff Ricky Lott filed for entry of default today in the Southern District of Florida after Health Gorilla blew past its response deadline. And it wasn't the only deadline they missed....
Revolution Medicines' Pancreatic Cancer Drug Shows Late‑Stage Success
This is big. All cancers suck. Pancreatic somehow manages to suck even more. Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial https://t.co/rFVsvi0mQD
Virtual Subspecialty Care Can Cut Unnecessary Transfers
You can't snap your fingers and make more subspecialists. So how does America close the gap? New Lifers episode with Dr. Chris Gallagher and Dr. Blake Porter at @AccessTeleCare on what virtual subspecialty care can actually fix. We discuss: * Why 2025...